Bristol-Myers (BMY) Q4 Earnings & Sales Beat, Stock Gains

Bristol-Myers Squibb Company (BMY) reported better-than-expected results for the fourth quarter of 2023 on the back of growth in its new product portfolio. The company reported adjusted earnings per share of $1.70, which beat the Zacks Consensus Estimate of $1.52. In the year-ago quarter, BMY posted adjusted earnings of $1.82.Total revenues of $11.5 billion surpassed the Zacks Consensus Estimate of $11.1 billion. Revenues increased 1% from the year-ago period due to higher sales of new product portfolio, as ...